Contraception Clinical Trial Landscape
Data updated: May 20, 2026
47 clinical trials tracked since 2008
Contraception is being studied across 47 clinical trials registered since 2008, with 13 programs currently active. The competitive pipeline includes 3 active Phase 3 trials, 6 active Phase 2 trials, and 3 active Phase 1 trials. Top industry sponsors include YourChoice Therapeutics, Inc., Mylan Pharmaceuticals Inc, Next Life Sciences.
13 active
/
47 total (since 2008)
3
Phase 1 Active
12 total
6
Phase 2 Active
16 total
3
Phase 3 Active
13 total
2
Phase 4 Active
9 total
Top Industry Sponsors
Sorted by active Active Done Failed
YourChoice Therapeutics, Inc. 1 1 0
Mylan Pharmaceuticals Inc 1 0 0
Next Life Sciences 1 0 0
Bayer 0 3 0
Featured Phase 3 Trials
NCT06672016 ACTIVE NOT RECRUITING
Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potential
Mylan Pharmaceuticals Inc n=1,630
NCT06394999 RECRUITING
Efficacy, Safety, and Acceptability of Mifepristone 50 mg Once-weekly as a Contraceptive
Leiden University Medical Center n=1,186
NCT02275546 COMPLETED
Performance and Safety of Vaginal Ring Applicator in Healthy Females (MK-8342A-063)
Organon and Co n=164
NCT03614494 COMPLETED
Piroxicam and Levonorgestrel Co-treatment for Emergency Contraception
Dr. Hang Wun Raymond Li n=860
+ 8 more Phase 3 trials — see full database below
Contraception — Trials Started by Year (last 10 years)
2016 2
2017 5
2018 4
2019 0
2020 2
2021 3
2022 3
2023 3
2024 1
2025 6
2026 1
TheraRadar.com
Full Trial Database
Complete sponsor table, every trial across all phases, plus competitive analytics. Sortable, filterable, exportable for Pro users.
Top Sponsors (all-time)
YourChoice Therapeutics, Inc. 2
Mylan Pharmaceuticals Inc 1
Next Life Sciences 1
Bayer 3
Lupin Research Inc 2
HRA Pharma 2
Organon and Co 1
Teva Branded Pharmaceutical Products R&D, Inc. 1
Teva Women's Health 1
Duramed Research 1
Active Trials by Phase
Phase 1 3
Phase 2 6
Phase 3 3
Phase 4 2
Enrollment Size Distribution
1-50 13
51-200 15
201-500 7
501-1k 4
1k+ 7
All Industry Sponsors
Sorted by active Active Done Failed
YourChoice Therapeutics, Inc. 1 1 0
Mylan Pharmaceuticals Inc 1 0 0
Next Life Sciences 1 0 0
Bayer 0 3 0
NCT06672016 ACTIVE NOT RECRUITING
Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potential
Mylan Pharmaceuticals Inc n=1,630
NCT07449299 NOT YET RECRUITING
Rct Assessing Pregnancy - Piroxicam for Ec With Levonorgestrel
University of Utah n=1,458
NCT06394999 RECRUITING
Efficacy, Safety, and Acceptability of Mifepristone 50 mg Once-weekly as a Contraceptive
Leiden University Medical Center n=1,186
NCT02275546 COMPLETED
Performance and Safety of Vaginal Ring Applicator in Healthy Females (MK-8342A-063)
Organon and Co n=164
NCT03614494 COMPLETED
Piroxicam and Levonorgestrel Co-treatment for Emergency Contraception
Dr. Hang Wun Raymond Li n=860
NCT03208985 COMPLETED
A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC Conditions
HRA Pharma n=1,270
NCT04089852 WITHDRAWN
Nitrous Oxide for Pain Management During IUD Insertion in Nulliparous Adolescent Women
Boston Children's Hospital
NCT02866643 COMPLETED
Labor and Delivery Implant Insertion: A Randomized Controlled Trial
Stanford University n=95
NCT01178125 COMPLETED
A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy
Teva Branded Pharmaceutical Products R&D, Inc. n=2,858
NCT02078063 COMPLETED
Analgesia for Insertion of Intrauterine Contraception
Karolinska Institutet n=86
NCT00996580 COMPLETED
A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy
Teva Women's Health n=3,597
Data: ClinicalTrials.gov · Trials registered 2008 onwards · Industry sponsors only